Study

Evidence of the neuroprotective role of citicoline in glaucoma patients. – Cost Effective Supplements

Evidence of the neuroprotective role of citicoline in glaucoma patients.

Quick navigation


http://www.ncbi.nlm.nih.gov/pubmed/18929133


Conclusion of this study

However, partial regression of this improvement was detected after two 120-day periods of washout. This suggests that the beneficial effects observed are in part treatment-dependent. The extension of citicoline treatment up to a period of 8 years lead to the stabilization or improvement of the glaucomatous visual dysfunction. These results suggest potential neuroprotective effects of citicoline in the glaucomatous disease.


Supplements analyzed in this study

CDP-choline

Health conditions analyzed in this study

No health conditions information for this study.

Functions related to this study

Visual health


Slightly Positive
CDP-choline


Body systems related to this study


Ocular System
Scroll to top